Stibbe advises on the equity offering of ProQR

Matter
NL Law
Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). 

ProQR is a biopharmaceutical company creating transformative RNA medicines for the treatment of severe genetic rare diseases and listed on Nasdaq.